Researchers say woman treated for neuroblastoma as a child is longest known survivor after having CAR T-cell therapy
A woman treated with a pioneering type of immunotherapy for a solid tumour has been in remission for more than 18 years with no further treatments, experts have revealed.
The therapy involves taking T-cells, a type of white blood cell, from a patient and genetically engineering them to target and kill cancer cells. These modified T-cells are grown in a laboratory and then infused back into the patient.
About Author
More Stories
Revealed: Chinese researchers can access half a million UK GP records
The Trump administration is sabotaging your scientific data | Jonathan Gilmour
Be a sim-only saver: could you join the phone users shunning bundles?